Diabetes care stocks
Heavily traded in Diabetes care
Turnover over $10M/day6 of about 20 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 30, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| DXCMDexCom, Inc. | $278.20M | +17.23% | — |
| PODDInsulet Corporation | $208.51M | −51.77% | Reports Nov 4, 2026 |
| TNDMTandem Diabetes Care, Inc. | $33.60M | +30.63% | Reports Nov 5, 2026 |
| MNKDMannKind Corporation | $11.20M | −36.82% | Reports Nov 4, 2026 |
| 6523.TPHC Holdings Corporation | $1.14B | +35.49% | Reports Nov 11, 2026 |
| BBNXBeta Bionics, Inc. | $16.62M | −34.38% | — |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
23 companies, largest market value first.
Data as of Oct 30, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| DXCM | DexCom, Inc. | $30.16B | Large cap | +17.23% |
| D1EX34.SA | DexCom, Inc. | $29.95B | Large cap | +17.28% |
| PODD | Insulet Corporation | $10.58B | Large cap | −51.77% |
| TNDM | Tandem Diabetes Care, Inc. | $1.38B | Small cap | +30.63% |
| MNKD | MannKind Corporation | $1.10B | Small cap | −36.82% |
| 6523.T | PHC Holdings Corporation | $1.10B | Small cap | +35.49% |
| BBNX | Beta Bionics, Inc. | $955.77M | Small cap | −34.38% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +34.48% |
| EMBC | Embecta Corp. | $371.69M | Small cap | −50.39% |
| SABS | SAB Biotherapeutics, Inc. | $293.89M | Small cap | +6.25% |
| ORMP | Oramed Pharmaceuticals Inc. | $173.12M | Small cap | +91.45% |
| BIOM3.SA | Biomm S.A. | $135.91M | Small cap | −31.41% |
| VTVT | vTv Therapeutics Inc. | $104.30M | Small cap | +25.20% |
| T2ND34.SA | Tandem Diabetes Care, Inc. | $91.44M | Micro cap | +36.94% |
| BMEA | Biomea Fusion, Inc. | $45.14M | Micro cap | −54.54% |
| MODD | Modular Medical, Inc. | $16.33M | Micro cap | −89.06% |
| POXEL.PA | Poxel S.A. | $9.98M | Micro cap | −30.42% |
| TRIB | Trinity Biotech plc | $5.39M | Micro cap | +569.70% |
| GCTK | GlucoTrack, Inc. | $1.65M | Micro cap | −78.45% |
| LABT | Lakewood-Amedex Biotherapeutics, Inc. | $562.33K | Micro cap | −97.26% |
| ADOC.PA | Adocia SA | — | — | −75.91% |
| AREC.L | Arecor Therapeutics plc | — | — | +13.79% |
| DMYD-B.ST | Diamyd Medical AB (publ) | — | Small cap | −90.56% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 23 companies grouped under the Diabetes care theme. The median market value in the group is $233.50M. Among the 18 with a price from the latest session, the median move over the past trading day is +1.25%. 52% of the 21 with a 200-day average trade above it. Price change over the past year runs from −86.9% to +36.6% across the middle 80 percent of the group, with a median of −30.4%.